The diagnostics company Myriad Genetics introduces a DNA test that could reveal a woman’s risk even if she doesn’t have one of the gene variants now associated with the disease

Quick Read

Whether Fusobacterium nucleatum causes colon tumors is unknown. But a new study hints that it may be ‘an integral part of the cancer.’

Quick Read

For some, progress cannot come soon enough. Running short on time, dying cancer patients are concocting do-it-yourself versions of highly experimental cancer therapies, without the oversight of doctors or regulators

Quick Read

Total costs of Kymriah and the 21 similar drugs in development — known as CAR T-cell therapies — will be far higher than many have imagined, reaching $1 million or more per patient, according to leading cancer experts. The next CAR T-cell drug could be approved as soon as November.

Quick Read

Lori Wallace says it’s frustrating to constantly hear messages in ads for hospitals that imply her cancer would go away if she were just more positive and tried harder

Quick Read

In a deal similar to the one that turned the tide against AIDS, manufacturers and charities will make chemotherapy drugs available in six poor countries at steep discounts

Quick Read

The approval of gene therapy for leukemia, expected in the next few months, will open the door to a radically new class of cancer treatments

Quick Read

Few may realize that ill-advised screening tests come at a price, and not just a monetary one that adds many billions to the nation’s health care bill. Every screening test has a rate of false positive results – misleading indications of a possible cancer that requires additional, usually invasive, testing with its own rate of complications

Quick Read